Michael E. Williams

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.

A. Tulpule, B. Cheson, Michael E. Williams, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.

J. Friedberg, B. Cheson, Michael E. Williams, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.